IDEAYA Biosciences(IDYA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 IDEAYA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, Calif., August 5, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology company committed to advancing the discovery, development, and commercialization of transformative precision medicines to address unmet medical needs in cancer, provided a business update and announced financial results for the second quarter ended June 30, 2025. Darovasertib • Metasta ...